Perspective · 10 Sep 2026
Conference abstractPublished 22 Oct 2012
Tissue-specific auto antibodies in systemic lupus erythematosus
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Systemic lupus erythematosus (SLE) is a chronic complex autoimmune disease involving multi-organ and organ systems. At the devastating disease stage, abnormal immune response can lead to vital damage to the kidneys, brain, heart, blood vessels, and lungs. Although anti-nuclear auto antibodies have been shown to play an important role in SLE disease pathogenesis, the types of auto antibodies causing specific end-organ manifestations are still unclear. To identify auto antibodies that may lead to organ-specific damage in SLE, we generated a large panel of recombinant monoclonal antibodies from SLE patients using the advanced single cell RT-PCR technology. We screened the recombinant antibodies for their reactivity to different tissue cells including neutrophils, blood vessel endothelial cells, and neuronal cells. For the antibodies that react with those cells, protein array or immunoprecipitation assays followed by mass spectrometry analysis are performed to identify their cognate antigens. In particular, we have identified that SLE-derived S4Ab2 antibody recognizes membrane bound protein disulfide isomerase (PDI) and S4Ab4 antibody recognizes a novel pattern recognition receptor NLRC5/NOD27. Administration of either antibody in NZB/W F1 lupus-prone mice induced transient proteinuria and kidney damage. Furthermore, SLE patients with active disease have increased titers of anti-PDI and anti-NLRC5 antibodies in their sera. Our studies suggest that anti-PDI and anti-NLRC5 auto antibodies may play an important role in the disease progression and organ damage in SLE patients.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Kaihong Su”

